U. S. Senators Menendez and Booker Stop by Prokaryotics Labs During Visit to Kean University

From left: Senator Menendez, Sang Lee, Tim Waddell, Holly Sutterlin, Senator Booker, Ellen Xia, Terry Roemer, Kean President Repollet, Bob Wilkening in the Prokaryotics Labs

Union, NJ – March 28, 2023 -- U. S. Senators Robert Menendez and Cory Booker visited Kean University on March 28 to celebrate the $18 million in federal funding they recently helped secure to support NJ Higher Education. From this appropriation, Kean will receive $4.25 million and the Institute for Life Sciences Entrepreneurship (ILSE) housed in the Kean STEM building will receive $2.5 million to expand its labs. In his remarks, ILSE president Tom Richardson highlighted the success of ILSE member Prokaryotics in securing more than $20 million dollars of its own grant funding from the NIH over the past 5 years. After the presentations, Senators Booker and Menendez along with Kean President Lamont O. Repollet stopped by the Prokaryotics Labs for a tour and impromptu photoshoot with the Prokaryotics staff!

Echoing the sentiments expressed by the Senators, all of us at Prokaryotics are exceptionally proud to be part of the vital and growing biotech research community in New Jersey, especially that located at Kean University.
-- Dr. Tim Waddell, Ph.D., Co-Founder and Vice President, Head of Chemistry

About Prokaryotics, Inc.
Prokaryotics, Inc. is a biopharmaceutical company founded on Merck & Co. out-licensed antibiotic assets under development to treat life-threatening AMR bacterial infections. Prokaryotics leverages its deep expertise in bacterial physiology, medicinal chemistry, collaborative spirit, and scientific passion to discover and develop new classes of antibiotics targeting outer membrane biogenesis – the fundamental armor erected by bacteria to naturally withstand the effects of antibiotics and innate immunity.

Media Contact:
Holly Sutterlin
908 737-1922 x124
hsutterlin@prokaryotics.com